Henry Schein stock (US42548G1040): Distributor of dental and medical supplies

Henry Schein, a leading distributor of health care products, continues to serve dental, medical, and veterinary practices across North America and globally. The company's shares trade on Nasdaq.

Henry Schein maintains its position as a key supplier in the health care distribution sector, providing products and services to dental, medical, and animal health professionals. The company reported steady operations in its most recent quarterly results, focusing on its core segments amid ongoing market dynamics.

As of: 11.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Henry Schein
• Sector/industry: Health care distribution
• Headquarters/country: United States
• Core markets: North America, Europe, Asia-Pacific
• Key revenue drivers: Dental, medical, animal health products
• Home exchange/listing venue: Nasdaq (HSIC)
• Trading currency: USD

Henry Schein: core business model

Henry Schein operates as a global distributor of health care products and services, primarily targeting dental, medical, and animal health practices. The company offers a wide range of consumables, equipment, and technology solutions to support professional workflows. This model allows Henry Schein to leverage economies of scale in procurement and distribution, serving over one million customers worldwide.

Founded in 1932, Henry Schein has expanded through organic growth and strategic acquisitions, establishing a presence in more than 30 countries. Its business is divided into two main segments: Health Care Distribution, which includes dental and medical products, and Technology and Value-Added Services, encompassing software and practice management tools. This diversified approach helps mitigate risks associated with any single market segment.

Main revenue and product drivers for Henry Schein

The dental distribution segment remains Henry Schein's largest revenue contributor, accounting for a significant portion of sales through supplies like gloves, anesthetics, and impression materials. Medical products, including pharmaceuticals and diagnostics, drive growth in physician offices and pharmacies. Animal health offerings, such as vaccines and surgical instruments, cater to veterinary clinics, reflecting the company's broad exposure to health care needs.

Technology solutions, including practice management software and e-commerce platforms, enhance customer retention and recurring revenue. Henry Schein's private-label brands and direct sales model further bolster margins. For US investors, the company's dominant position in the North American dental market provides stable exposure to essential health care spending.

Industry trends and competitive position

The health care distribution industry faces trends like digital transformation, supply chain resilience, and consolidation. Henry Schein invests in cloud-based software and AI-driven inventory management to stay competitive. Competitors include Patterson Companies and Benco Dental, but Henry Schein's global scale and integrated services set it apart.

In the US, where dental spending exceeds $150 billion annually, Henry Schein's market leadership supports consistent performance. The shift toward value-based care and telemedicine indirectly benefits distributors by increasing demand for efficient supply chains.

Why Henry Schein matters for US investors

Listed on Nasdaq under ticker HSIC, Henry Schein offers US investors access to a resilient sector less sensitive to economic cycles. Health care distribution benefits from recurring demand, with the US representing over 50% of the company's revenue. Exposure to veterinary and medical segments diversifies beyond pure dental reliance.

Read more

Conclusion

Henry Schein continues to execute its distribution model across key health care verticals, maintaining a strong foothold in the US market. Investors track its segment performance and acquisition strategy for insights into sector health. The company's scale positions it well amid evolving industry demands.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.